![Heikki Lanckriet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heikki Lanckriet
Directeur/Membre du Conseil chez
BIOFRONTERA AG
Fortune : 8 M $ au 31/05/2026
Profil
Heikki Lanckriet is the founder of Expedeon Ltd., founded in 2003, holding the titles of Chief Executive Officer & Chief Scientific Officer.
Dr. Lanckriet is the founder of Expedeon Holdings Ltd., founded in 2003, holding the title of Director.
Current jobs include Director at NeoPhore Ltd., Non-Executive Director at Kither Biotech Srl since 2022, Director at 4basebio Slu, Director at 4basebio UK Ltd. since 2019, Non-Executive Director at 4basebio Plc since 2026, Director at Biofrontera, Inc. since 2023, Director at Heqet Therapeutics Srl, Director at 4basebio Discovery Ltd., Director at I2i Capital Ltd., and Member-Supervisory Board at Biofrontera AG since 2021.
Former jobs include Chief Executive Officer & Chief Scientific Officer at 2invest AG from 2017 to 2020, Independent Member-Supervisory Board at Epigenomics AG from 2022 to 2024, Principal at Puratos NV, and Principal at the University of Cambridge.
Education includes a doctorate from the University of Cambridge and undergraduate and graduate degrees from Ghent University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
4BASEBIO PLC 7,23% | 10/02/2026 | 1 122 688 ( 7,23% ) | 8 M $ | 31/05/2026 |
BIOFRONTERA, INC. -.--% | 04/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Heikki Lanckriet
| Sociétés | Poste | Début |
|---|---|---|
| 4BASEBIO PLC | Directeur/Membre du Conseil | 22/12/2020 |
| BIOFRONTERA AG | Directeur/Membre du Conseil | 14/12/2021 |
| BIOFRONTERA INC. | Directeur/Membre du Conseil | 12/07/2023 |
Expedeon Ltd.
 Expedeon Ltd. BiotechnologyHealth Technology Develops and produces proteins for drug discovery | Directeur Général | 07/01/2010 |
Heqet Therapeutics SRL
 Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in cardiac regenerative medicine | Directeur/Membre du Conseil | - |
I2i Capital Ltd. | Directeur/Membre du Conseil | - |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Directeur/Membre du Conseil | - |
4basebio Slu | Directeur/Membre du Conseil | - |
4basebio Discovery Ltd. | Directeur/Membre du Conseil | - |
| ░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Heikki Lanckriet
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Heikki Lanckriet
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
2invest AG
 2invest AG Financial ConglomeratesFinance Operates as an investment holding company primarily investing in biotechnology | Finance |
Epigenomics AG
 Epigenomics AG Medical SpecialtiesHealth Technology Engages in the development and commercialization of in vitro diagnostic tests for cancer | Health Technology |
Puratos NV
 Puratos NV Food: Specialty/CandyConsumer Non-Durables Manufactures food ingredients for bakery, patisserie and chocolate sectors | Consumer Non-Durables |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biofrontera AG
 Biofrontera AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops and distributes dermatological products | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expedeon Ltd.
Expedeon Ltd. BiotechnologyHealth Technology Develops and produces proteins for drug discovery | Health Technology |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Develops, manufactures, and commercializes proteomics reagents and tools | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Commercial Services |
Kither Biotech Srl
 Kither Biotech Srl Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products | Health Technology |
4basebio Slu | |
4basebio UK Ltd.
 4basebio UK Ltd. Wholesale DistributorsDistribution Services Supplies deoxyribonucleic acid for use in gene therapies and vaccines | Distribution Services |
4basebio Plc
 4basebio Plc BiotechnologyHealth Technology Develops gene therapy technologies and manufactures synthetic DNA | Health Technology |
Biofrontera, Inc.
 Biofrontera, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes dermatological drugs | Health Technology |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in cardiac regenerative medicine | Health Technology |
4basebio Discovery Ltd. | |
I2i Capital Ltd. |
